Home Tags #Lexicon Pharmaceuticals

Tag: #Lexicon Pharmaceuticals

What Are Value Traders’ Views on Lexicon Pharmaceuticals, Inc. (LXRX), Zayo...

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), with a trailing 12-month price-to-sales ratio of 9.95, is now among the bigger bargains in its industry. The broad Biotechnology...

Lexicon Pharmaceuticals, Inc. (LXRX) Becoming A Gem To Institutional Investors?

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) went up to recover about 39.29% since recording its record low price of $4.25. The stock experienced 3.32% jump, arriving...

ContraVir Pharmaceuticals, Inc. (CTRV) And Lexicon Pharmaceuticals, Inc. (LXRX) Struggle for...

Shares of ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) opened at $0.195, and ended 28.45% higher at $0.28. Nearly 3399457 shares were traded by the close, higher...

Potential Opportunity To Buy or Exit? – Lexicon Pharmaceuticals, Inc. (LXRX),...

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is simply too cheap to pass with a price-to-sales ratio of 9.35. The competitors from Biotechnology hold an average P/S...

Can A Similar Series of Events Expected At Lexicon Pharmaceuticals, Inc....

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) enjoyed a fine run from the open in trading on 03/29/2019 with decreased volume coming into the shares and a...

Lexicon Pharmaceuticals, Inc. (LXRX) And iQIYI, Inc. (IQ) Both Trading At...

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) current P/S is an impressive 9.1. The overall Biotechnology group has an average P/S ratio of 46.7, which is significantly...

Is This A Much-Needed Relief Rally For Lexicon Pharmaceuticals, Inc. (LXRX)?

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) recovered 27.29% of its value since hitting low of $4.25. The recent move of -4.42% drop pushed the stock to...

Investors Have Had Multiple Reasons To Watch Entree Resources Ltd. (EGI),...

Entree Resources Ltd. (NYSE:EGI) recent gain occurred on high volume with 326153 contracts changing hands on 25-Mar-19. That's greater from its daily average of...

Stock Analysts Offer Mixed Views On Plantronics, Inc. (PLT), Lexicon Pharmaceuticals,...

Plantronics, Inc. (NYSE:PLT) enjoyed a weak run from the open in trading on 03/22/2019 with increased volume coming into the shares and a close...

Lexicon Pharmaceuticals, Inc. (LXRX) And Marvell Technology Group Ltd. (MRVL) Both...

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is simply too cheap to pass with a price-to-sales ratio of 15.28. The competitors from Biotechnology hold an average P/S...